C60S (p.Cys60Ser) variant of KRT17 (Keratin, type I cytoskeletal 17)

C60S (p.Cys60Ser) in KRT17 (Keratin, type I cytoskeletal 17) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.42 / 1. The record also includes population frequency data and structural context.

C60S (p.Cys60Ser) variant details